| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatrics | 71 | 2025 | 421 | 15.910 |
Why?
|
| Neonatal Screening | 39 | 2026 | 71 | 12.820 |
Why?
|
| Parents | 51 | 2026 | 321 | 10.960 |
Why?
|
| Living Donors | 41 | 2023 | 375 | 9.950 |
Why?
|
| Genetic Testing | 44 | 2025 | 594 | 7.890 |
Why?
|
| Decision Making | 45 | 2025 | 685 | 7.760 |
Why?
|
| Kidney Transplantation | 39 | 2024 | 939 | 7.270 |
Why?
|
| Tissue and Organ Procurement | 35 | 2025 | 423 | 6.620 |
Why?
|
| Periodicals as Topic | 16 | 2023 | 175 | 5.630 |
Why?
|
| Informed Consent | 45 | 2021 | 281 | 5.600 |
Why?
|
| Child | 123 | 2025 | 7680 | 5.570 |
Why?
|
| Phenylketonurias | 13 | 2025 | 17 | 4.890 |
Why?
|
| Organ Transplantation | 16 | 2025 | 306 | 4.870 |
Why?
|
| Attitude of Health Personnel | 27 | 2026 | 684 | 4.790 |
Why?
|
| Human Experimentation | 17 | 2022 | 41 | 3.840 |
Why?
|
| Tissue Donors | 21 | 2024 | 581 | 3.750 |
Why?
|
| Personal Autonomy | 26 | 2024 | 125 | 3.650 |
Why?
|
| Humans | 321 | 2026 | 97893 | 3.630 |
Why?
|
| Ethics, Medical | 30 | 2026 | 292 | 3.480 |
Why?
|
| Infant, Newborn | 55 | 2026 | 2529 | 3.420 |
Why?
|
| Physician-Patient Relations | 17 | 2026 | 580 | 3.300 |
Why?
|
| Bioethics | 10 | 2022 | 37 | 3.250 |
Why?
|
| Cystic Fibrosis | 16 | 2026 | 123 | 3.240 |
Why?
|
| Kidney Failure, Chronic | 11 | 2020 | 445 | 3.210 |
Why?
|
| Ethics, Research | 14 | 2026 | 54 | 3.130 |
Why?
|
| Parental Consent | 22 | 2020 | 36 | 2.970 |
Why?
|
| United States | 104 | 2026 | 8183 | 2.940 |
Why?
|
| Anemia, Sickle Cell | 10 | 2022 | 158 | 2.880 |
Why?
|
| Truth Disclosure | 9 | 2024 | 75 | 2.520 |
Why?
|
| Health Policy | 13 | 2021 | 216 | 2.360 |
Why?
|
| Youth Sports | 4 | 2020 | 10 | 2.270 |
Why?
|
| Physicians | 15 | 2026 | 685 | 2.260 |
Why?
|
| Adolescent | 58 | 2025 | 10078 | 2.240 |
Why?
|
| Moral Obligations | 10 | 2020 | 54 | 2.160 |
Why?
|
| Siblings | 8 | 2024 | 113 | 2.140 |
Why?
|
| Pediatricians | 4 | 2020 | 25 | 2.120 |
Why?
|
| History, 20th Century | 19 | 2021 | 323 | 2.060 |
Why?
|
| Directive Counseling | 5 | 2020 | 34 | 2.030 |
Why?
|
| Biomedical Research | 8 | 2020 | 470 | 2.030 |
Why?
|
| Treatment Refusal | 9 | 2024 | 69 | 2.010 |
Why?
|
| Genetic Counseling | 14 | 2025 | 110 | 1.970 |
Why?
|
| Confidentiality | 19 | 2026 | 77 | 1.970 |
Why?
|
| Bioethical Issues | 11 | 2020 | 39 | 1.920 |
Why?
|
| Authorship | 4 | 2023 | 29 | 1.900 |
Why?
|
| Patient Selection | 13 | 2018 | 720 | 1.840 |
Why?
|
| Ethics Committees, Research | 12 | 2023 | 34 | 1.770 |
Why?
|
| Sickle Cell Trait | 5 | 2013 | 21 | 1.720 |
Why?
|
| Risk Assessment | 31 | 2021 | 2580 | 1.720 |
Why?
|
| Health Knowledge, Attitudes, Practice | 11 | 2026 | 601 | 1.710 |
Why?
|
| Brain Death | 5 | 2023 | 94 | 1.710 |
Why?
|
| Genetic Carrier Screening | 10 | 2011 | 58 | 1.590 |
Why?
|
| Attitude | 9 | 2019 | 133 | 1.590 |
Why?
|
| Research Subjects | 12 | 2020 | 80 | 1.550 |
Why?
|
| Family | 15 | 2023 | 327 | 1.540 |
Why?
|
| Female | 96 | 2026 | 51463 | 1.540 |
Why?
|
| Disclosure | 9 | 2016 | 98 | 1.510 |
Why?
|
| Altruism | 8 | 2018 | 35 | 1.500 |
Why?
|
| Publishing | 6 | 2022 | 97 | 1.480 |
Why?
|
| Social Justice | 8 | 2022 | 62 | 1.470 |
Why?
|
| Vaccination | 7 | 2025 | 323 | 1.440 |
Why?
|
| Incidental Findings | 6 | 2015 | 100 | 1.440 |
Why?
|
| Genetic Diseases, Inborn | 7 | 2019 | 104 | 1.430 |
Why?
|
| Clinical Trials as Topic | 12 | 2021 | 1125 | 1.430 |
Why?
|
| Withholding Treatment | 5 | 2020 | 129 | 1.410 |
Why?
|
| Family Relations | 7 | 2021 | 38 | 1.390 |
Why?
|
| Male | 82 | 2026 | 46995 | 1.390 |
Why?
|
| Minors | 9 | 2020 | 15 | 1.370 |
Why?
|
| Data Collection | 15 | 2014 | 375 | 1.360 |
Why?
|
| Bibliometrics | 5 | 2023 | 49 | 1.320 |
Why?
|
| Child Welfare | 8 | 2020 | 44 | 1.300 |
Why?
|
| Morals | 6 | 2023 | 105 | 1.300 |
Why?
|
| Government Regulation | 10 | 2006 | 49 | 1.290 |
Why?
|
| Child Health | 2 | 2021 | 15 | 1.270 |
Why?
|
| Sequence Analysis, DNA | 5 | 2025 | 911 | 1.270 |
Why?
|
| Directed Tissue Donation | 5 | 2017 | 8 | 1.270 |
Why?
|
| Resource Allocation | 5 | 2019 | 65 | 1.260 |
Why?
|
| Child Abuse | 4 | 2020 | 97 | 1.260 |
Why?
|
| Health Behavior | 3 | 2016 | 200 | 1.250 |
Why?
|
| Patient Participation | 9 | 2020 | 246 | 1.240 |
Why?
|
| Human Rights | 5 | 2018 | 21 | 1.230 |
Why?
|
| Brain Concussion | 4 | 2020 | 88 | 1.230 |
Why?
|
| Community-Based Participatory Research | 4 | 2010 | 40 | 1.230 |
Why?
|
| Attitude to Health | 8 | 2010 | 217 | 1.230 |
Why?
|
| Transplant Recipients | 5 | 2025 | 182 | 1.200 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2019 | 658 | 1.160 |
Why?
|
| Mandatory Programs | 5 | 2025 | 8 | 1.140 |
Why?
|
| Prenatal Diagnosis | 6 | 2019 | 107 | 1.140 |
Why?
|
| Fragile X Syndrome | 5 | 2015 | 17 | 1.130 |
Why?
|
| Athletic Injuries | 3 | 2020 | 113 | 1.130 |
Why?
|
| Phenylalanine | 4 | 2018 | 31 | 1.120 |
Why?
|
| Public Health | 4 | 2022 | 161 | 1.120 |
Why?
|
| Ethical Analysis | 7 | 2022 | 23 | 1.100 |
Why?
|
| Policy Making | 10 | 2021 | 64 | 1.090 |
Why?
|
| Muscular Dystrophy, Duchenne | 7 | 2015 | 42 | 1.090 |
Why?
|
| Biological Specimen Banks | 4 | 2012 | 82 | 1.080 |
Why?
|
| Physician's Role | 5 | 2018 | 181 | 1.050 |
Why?
|
| Adolescent Health Services | 2 | 2024 | 14 | 1.050 |
Why?
|
| Therapeutic Misconception | 2 | 2021 | 5 | 1.040 |
Why?
|
| Caregivers | 5 | 2026 | 200 | 1.020 |
Why?
|
| Adult | 55 | 2026 | 29453 | 1.000 |
Why?
|
| Mental Competency | 10 | 2016 | 49 | 1.000 |
Why?
|
| Community-Institutional Relations | 4 | 2010 | 33 | 1.000 |
Why?
|
| Waiting Lists | 14 | 2022 | 237 | 0.990 |
Why?
|
| Vaccination Refusal | 3 | 2022 | 15 | 0.980 |
Why?
|
| Patient Advocacy | 5 | 2020 | 67 | 0.980 |
Why?
|
| Socioeconomic Factors | 7 | 2020 | 661 | 0.980 |
Why?
|
| Vulnerable Populations | 3 | 2020 | 95 | 0.970 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2014 | 977 | 0.970 |
Why?
|
| Heterozygote | 5 | 2012 | 390 | 0.960 |
Why?
|
| Diabetes Mellitus, Type 1 | 8 | 2021 | 686 | 0.910 |
Why?
|
| Palliative Care | 4 | 2026 | 289 | 0.900 |
Why?
|
| Guidelines as Topic | 9 | 2020 | 169 | 0.900 |
Why?
|
| Research Design | 9 | 2021 | 650 | 0.900 |
Why?
|
| Pregnancy | 14 | 2024 | 3246 | 0.890 |
Why?
|
| Nontherapeutic Human Experimentation | 4 | 2007 | 19 | 0.880 |
Why?
|
| Research Personnel | 6 | 2026 | 85 | 0.880 |
Why?
|
| Clinical Decision-Making | 4 | 2024 | 304 | 0.880 |
Why?
|
| Infant | 18 | 2025 | 3329 | 0.880 |
Why?
|
| Maple Syrup Urine Disease | 2 | 2018 | 5 | 0.860 |
Why?
|
| Child, Preschool | 20 | 2025 | 4000 | 0.860 |
Why?
|
| Surveys and Questionnaires | 18 | 2026 | 3021 | 0.860 |
Why?
|
| Child Advocacy | 5 | 2011 | 9 | 0.850 |
Why?
|
| Mothers | 7 | 2011 | 146 | 0.850 |
Why?
|
| Parent-Child Relations | 11 | 2012 | 89 | 0.850 |
Why?
|
| Vaccines | 2 | 2025 | 86 | 0.850 |
Why?
|
| United Kingdom | 7 | 2024 | 208 | 0.850 |
Why?
|
| Live Birth | 1 | 2024 | 22 | 0.840 |
Why?
|
| Death | 2 | 2018 | 98 | 0.830 |
Why?
|
| Motivation | 5 | 2021 | 343 | 0.830 |
Why?
|
| Mass Media | 2 | 2020 | 26 | 0.810 |
Why?
|
| Risk | 11 | 2016 | 660 | 0.800 |
Why?
|
| Graft Survival | 8 | 2024 | 994 | 0.800 |
Why?
|
| Research | 6 | 2005 | 256 | 0.790 |
Why?
|
| Health Facilities | 1 | 2023 | 43 | 0.780 |
Why?
|
| Mass Screening | 4 | 2011 | 745 | 0.780 |
Why?
|
| ABO Blood-Group System | 7 | 2010 | 58 | 0.770 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2023 | 256 | 0.770 |
Why?
|
| Football | 3 | 2020 | 49 | 0.760 |
Why?
|
| Schools | 2 | 2020 | 93 | 0.760 |
Why?
|
| Minority Groups | 4 | 2006 | 156 | 0.760 |
Why?
|
| Hematologic Tests | 1 | 2022 | 17 | 0.760 |
Why?
|
| Registries | 5 | 2024 | 1120 | 0.760 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2023 | 59 | 0.750 |
Why?
|
| Healthcare Disparities | 5 | 2023 | 539 | 0.750 |
Why?
|
| Fetal Viability | 1 | 2022 | 11 | 0.750 |
Why?
|
| Heart Arrest | 2 | 2023 | 315 | 0.740 |
Why?
|
| Prisoners | 2 | 2018 | 48 | 0.730 |
Why?
|
| Life Support Care | 4 | 2018 | 58 | 0.730 |
Why?
|
| Chromosomes | 1 | 2022 | 91 | 0.730 |
Why?
|
| Lysosomal Storage Diseases | 2 | 2012 | 11 | 0.720 |
Why?
|
| Physician Executives | 2 | 2013 | 25 | 0.700 |
Why?
|
| Public Policy | 7 | 2008 | 61 | 0.680 |
Why?
|
| Faculty, Medical | 3 | 2023 | 193 | 0.680 |
Why?
|
| Women | 4 | 2008 | 26 | 0.680 |
Why?
|
| Drug Approval | 2 | 2018 | 69 | 0.680 |
Why?
|
| Ethics, Clinical | 5 | 2010 | 47 | 0.670 |
Why?
|
| Pandemics | 4 | 2025 | 913 | 0.670 |
Why?
|
| Mass Vaccination | 1 | 2021 | 10 | 0.670 |
Why?
|
| Policy | 2 | 2011 | 41 | 0.660 |
Why?
|
| Kidney | 4 | 2017 | 1121 | 0.660 |
Why?
|
| Practice Guidelines as Topic | 14 | 2020 | 1108 | 0.660 |
Why?
|
| Efficiency | 1 | 2020 | 39 | 0.650 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2020 | 4 | 0.650 |
Why?
|
| Curriculum | 3 | 2015 | 633 | 0.650 |
Why?
|
| Ribonucleotide Reductases | 1 | 2020 | 6 | 0.650 |
Why?
|
| Neoplasms | 6 | 2025 | 3340 | 0.650 |
Why?
|
| Internship and Residency | 4 | 2015 | 1120 | 0.640 |
Why?
|
| Genomics | 4 | 2021 | 898 | 0.640 |
Why?
|
| Third-Party Consent | 7 | 2009 | 24 | 0.630 |
Why?
|
| Health Equity | 2 | 2020 | 116 | 0.630 |
Why?
|
| Ethics | 7 | 2009 | 24 | 0.620 |
Why?
|
| Hemoglobin, Sickle | 1 | 2020 | 17 | 0.620 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2021 | 195 | 0.610 |
Why?
|
| Information Dissemination | 2 | 2019 | 133 | 0.610 |
Why?
|
| Intellectual Disability | 1 | 2021 | 202 | 0.610 |
Why?
|
| Infant, Premature | 2 | 2022 | 305 | 0.610 |
Why?
|
| Liver Transplantation | 4 | 2018 | 1234 | 0.600 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2025 | 2555 | 0.600 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2019 | 28 | 0.600 |
Why?
|
| Craniocerebral Trauma | 1 | 2020 | 55 | 0.590 |
Why?
|
| Health Personnel | 3 | 2011 | 257 | 0.590 |
Why?
|
| Education, Medical, Graduate | 3 | 2015 | 449 | 0.590 |
Why?
|
| Nephrology | 1 | 2020 | 57 | 0.580 |
Why?
|
| Tissue Banks | 3 | 2008 | 16 | 0.580 |
Why?
|
| Racism | 1 | 2021 | 107 | 0.580 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2019 | 87 | 0.580 |
Why?
|
| Phenylketonuria, Maternal | 1 | 2018 | 1 | 0.570 |
Why?
|
| Societies, Medical | 8 | 2015 | 682 | 0.570 |
Why?
|
| Medical History Taking | 1 | 2019 | 81 | 0.570 |
Why?
|
| History, 21st Century | 5 | 2021 | 196 | 0.560 |
Why?
|
| Medication Adherence | 1 | 2019 | 130 | 0.550 |
Why?
|
| Glucosephosphate Dehydrogenase Deficiency | 3 | 2006 | 8 | 0.550 |
Why?
|
| Guideline Adherence | 2 | 2019 | 249 | 0.550 |
Why?
|
| Risk Factors | 14 | 2024 | 6224 | 0.550 |
Why?
|
| Professional-Family Relations | 7 | 2014 | 60 | 0.540 |
Why?
|
| Leukodystrophy, Globoid Cell | 2 | 2015 | 7 | 0.540 |
Why?
|
| Interpersonal Relations | 2 | 2018 | 182 | 0.540 |
Why?
|
| Editorial Policies | 3 | 2021 | 37 | 0.540 |
Why?
|
| Physical Examination | 1 | 2019 | 149 | 0.540 |
Why?
|
| Papillomavirus Vaccines | 2 | 2008 | 60 | 0.540 |
Why?
|
| Ethics Consultation | 1 | 2018 | 13 | 0.530 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 419 | 0.530 |
Why?
|
| Paternalism | 6 | 2003 | 24 | 0.530 |
Why?
|
| Terminal Care | 2 | 2018 | 147 | 0.530 |
Why?
|
| Age Factors | 11 | 2024 | 1960 | 0.520 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 1286 | 0.520 |
Why?
|
| Health Status | 3 | 2015 | 385 | 0.520 |
Why?
|
| Refusal to Treat | 3 | 2010 | 27 | 0.520 |
Why?
|
| Paternity | 3 | 2011 | 7 | 0.520 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2021 | 314 | 0.520 |
Why?
|
| Neuromuscular Diseases | 1 | 2017 | 26 | 0.520 |
Why?
|
| Genetic Research | 3 | 2008 | 18 | 0.520 |
Why?
|
| Urban Population | 1 | 2018 | 246 | 0.510 |
Why?
|
| Choice Behavior | 1 | 2018 | 164 | 0.510 |
Why?
|
| Transplantation | 3 | 2010 | 39 | 0.510 |
Why?
|
| Donor Selection | 4 | 2024 | 86 | 0.500 |
Why?
|
| Middle Aged | 27 | 2026 | 29352 | 0.500 |
Why?
|
| Respiration, Artificial | 1 | 2020 | 430 | 0.500 |
Why?
|
| Direct-To-Consumer Screening and Testing | 2 | 2025 | 3 | 0.500 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2018 | 184 | 0.500 |
Why?
|
| Sexism | 1 | 2017 | 64 | 0.500 |
Why?
|
| Ethical Theory | 2 | 2016 | 10 | 0.500 |
Why?
|
| Physicians, Women | 1 | 2017 | 66 | 0.490 |
Why?
|
| Medical Errors | 2 | 2015 | 93 | 0.460 |
Why?
|
| Health Care Rationing | 2 | 2010 | 85 | 0.460 |
Why?
|
| Educational Status | 2 | 2013 | 205 | 0.440 |
Why?
|
| Communication | 8 | 2025 | 455 | 0.440 |
Why?
|
| Duty to Recontact | 1 | 2015 | 1 | 0.440 |
Why?
|
| Beneficence | 7 | 2018 | 36 | 0.440 |
Why?
|
| Health Services Accessibility | 5 | 2019 | 532 | 0.440 |
Why?
|
| Clinical Competence | 2 | 2012 | 863 | 0.430 |
Why?
|
| Coercion | 2 | 2012 | 16 | 0.430 |
Why?
|
| Therapeutic Human Experimentation | 4 | 2006 | 20 | 0.430 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 508 | 0.420 |
Why?
|
| Professional Competence | 2 | 2013 | 65 | 0.420 |
Why?
|
| Illinois | 5 | 2019 | 522 | 0.410 |
Why?
|
| Dissent and Disputes | 4 | 2023 | 28 | 0.410 |
Why?
|
| Herpes Simplex | 1 | 2015 | 79 | 0.410 |
Why?
|
| Social Values | 4 | 2007 | 44 | 0.410 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2015 | 94 | 0.410 |
Why?
|
| Child Abuse, Sexual | 1 | 2014 | 19 | 0.410 |
Why?
|
| Psychology, Adolescent | 1 | 2014 | 26 | 0.410 |
Why?
|
| Pilot Projects | 8 | 2013 | 968 | 0.410 |
Why?
|
| Histocompatibility | 2 | 2006 | 71 | 0.410 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2015 | 100 | 0.400 |
Why?
|
| Bone Marrow Transplantation | 2 | 2024 | 286 | 0.400 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 478 | 0.400 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2014 | 86 | 0.400 |
Why?
|
| Vaccination Coverage | 2 | 2025 | 7 | 0.400 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 102 | 0.390 |
Why?
|
| Adolescent Development | 2 | 2024 | 28 | 0.390 |
Why?
|
| Sex Factors | 4 | 2020 | 1137 | 0.390 |
Why?
|
| Health Physics | 1 | 2013 | 22 | 0.380 |
Why?
|
| Codes of Ethics | 3 | 2008 | 12 | 0.380 |
Why?
|
| Cadaver | 4 | 2012 | 202 | 0.380 |
Why?
|
| Residence Characteristics | 2 | 2012 | 224 | 0.380 |
Why?
|
| Infant Mortality | 1 | 2013 | 68 | 0.380 |
Why?
|
| Freedom | 7 | 1999 | 19 | 0.370 |
Why?
|
| Young Adult | 12 | 2025 | 7504 | 0.370 |
Why?
|
| Tyrosine | 1 | 2012 | 135 | 0.360 |
Why?
|
| Consensus | 2 | 2024 | 315 | 0.360 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 74 | 0.360 |
Why?
|
| Awareness | 1 | 2013 | 93 | 0.360 |
Why?
|
| Prejudice | 2 | 2010 | 51 | 0.360 |
Why?
|
| Efficiency, Organizational | 1 | 2012 | 55 | 0.360 |
Why?
|
| Community Participation | 1 | 2012 | 40 | 0.350 |
Why?
|
| Chicago | 7 | 2018 | 1513 | 0.350 |
Why?
|
| Cause of Death | 1 | 2013 | 278 | 0.350 |
Why?
|
| Public Opinion | 3 | 2021 | 55 | 0.350 |
Why?
|
| Surgery, Plastic | 1 | 2012 | 37 | 0.350 |
Why?
|
| Health Surveys | 3 | 2013 | 254 | 0.350 |
Why?
|
| Shame | 1 | 2011 | 4 | 0.350 |
Why?
|
| Transplants | 2 | 2022 | 43 | 0.340 |
Why?
|
| Postpartum Period | 1 | 2013 | 169 | 0.340 |
Why?
|
| Self Disclosure | 1 | 2011 | 29 | 0.340 |
Why?
|
| Athletes | 1 | 2011 | 63 | 0.340 |
Why?
|
| Focus Groups | 5 | 2012 | 214 | 0.340 |
Why?
|
| Asthma | 3 | 2005 | 1078 | 0.340 |
Why?
|
| Renal Dialysis | 4 | 2021 | 356 | 0.340 |
Why?
|
| Comprehension | 2 | 2011 | 94 | 0.330 |
Why?
|
| Sports | 1 | 2011 | 41 | 0.330 |
Why?
|
| Sweat | 1 | 2011 | 5 | 0.330 |
Why?
|
| Mandatory Testing | 1 | 2010 | 3 | 0.330 |
Why?
|
| Depression, Postpartum | 1 | 2011 | 17 | 0.330 |
Why?
|
| Sports Medicine | 1 | 2011 | 62 | 0.330 |
Why?
|
| Social Determinants of Health | 2 | 2023 | 132 | 0.330 |
Why?
|
| Mother-Child Relations | 1 | 2010 | 30 | 0.330 |
Why?
|
| Surgeons | 1 | 2015 | 325 | 0.320 |
Why?
|
| Placebos | 3 | 2005 | 209 | 0.320 |
Why?
|
| Resuscitation Orders | 2 | 2003 | 65 | 0.310 |
Why?
|
| Methylmalonic Acid | 1 | 2010 | 7 | 0.310 |
Why?
|
| Immunization Programs | 3 | 2008 | 28 | 0.310 |
Why?
|
| Medicine in Literature | 1 | 2010 | 8 | 0.310 |
Why?
|
| Philosophy, Medical | 1 | 2010 | 16 | 0.310 |
Why?
|
| Histocompatibility Testing | 5 | 2011 | 145 | 0.310 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2010 | 30 | 0.310 |
Why?
|
| Quality of Health Care | 3 | 2019 | 391 | 0.310 |
Why?
|
| Medical Oncology | 2 | 2021 | 421 | 0.310 |
Why?
|
| Hospital Mortality | 1 | 2013 | 518 | 0.310 |
Why?
|
| Risk Management | 1 | 2010 | 45 | 0.300 |
Why?
|
| Students | 1 | 2011 | 196 | 0.300 |
Why?
|
| Adaptation, Psychological | 1 | 2010 | 190 | 0.300 |
Why?
|
| Malpractice | 2 | 2002 | 47 | 0.300 |
Why?
|
| Counseling | 3 | 2009 | 191 | 0.300 |
Why?
|
| National Health Programs | 1 | 2009 | 19 | 0.290 |
Why?
|
| Neonatology | 2 | 2007 | 21 | 0.290 |
Why?
|
| Social Responsibility | 5 | 2007 | 53 | 0.290 |
Why?
|
| Health Care Surveys | 4 | 2019 | 282 | 0.290 |
Why?
|
| Fee-for-Service Plans | 1 | 2009 | 32 | 0.290 |
Why?
|
| Dyskeratosis Congenita | 1 | 2008 | 2 | 0.290 |
Why?
|
| Prenatal Care | 2 | 2013 | 81 | 0.290 |
Why?
|
| Nuclear Family | 1 | 2009 | 92 | 0.290 |
Why?
|
| Universities | 1 | 2009 | 166 | 0.280 |
Why?
|
| Public Health Administration | 1 | 2008 | 19 | 0.280 |
Why?
|
| Anemia, Aplastic | 1 | 2008 | 34 | 0.280 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2009 | 79 | 0.280 |
Why?
|
| Drug Prescriptions | 1 | 2010 | 158 | 0.270 |
Why?
|
| Self Care | 1 | 2010 | 188 | 0.270 |
Why?
|
| Resuscitation | 1 | 2009 | 134 | 0.270 |
Why?
|
| Elective Surgical Procedures | 1 | 2010 | 171 | 0.270 |
Why?
|
| Patient Education as Topic | 3 | 2012 | 417 | 0.270 |
Why?
|
| Research Support as Topic | 3 | 2010 | 97 | 0.270 |
Why?
|
| Personhood | 2 | 2006 | 16 | 0.270 |
Why?
|
| Communicable Diseases | 1 | 2008 | 74 | 0.270 |
Why?
|
| Fetal Blood | 1 | 2008 | 94 | 0.260 |
Why?
|
| Genetic Privacy | 3 | 2004 | 17 | 0.260 |
Why?
|
| Growth | 1 | 2007 | 42 | 0.250 |
Why?
|
| Soccer | 2 | 2017 | 20 | 0.250 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2012 | 108 | 0.250 |
Why?
|
| Conscience | 1 | 2007 | 20 | 0.250 |
Why?
|
| Ethical Review | 2 | 2004 | 8 | 0.250 |
Why?
|
| Value of Life | 1 | 2007 | 23 | 0.250 |
Why?
|
| Self Report | 2 | 2019 | 355 | 0.240 |
Why?
|
| Risk-Taking | 2 | 2005 | 159 | 0.240 |
Why?
|
| Publications | 2 | 2023 | 32 | 0.240 |
Why?
|
| Federal Government | 3 | 2006 | 28 | 0.240 |
Why?
|
| Violence | 3 | 2004 | 164 | 0.240 |
Why?
|
| Patient Access to Records | 1 | 2006 | 2 | 0.240 |
Why?
|
| Sexuality | 2 | 1996 | 40 | 0.230 |
Why?
|
| Persistent Vegetative State | 1 | 2006 | 9 | 0.230 |
Why?
|
| Pregnancy Outcome | 1 | 2008 | 278 | 0.230 |
Why?
|
| Congresses as Topic | 2 | 2017 | 123 | 0.230 |
Why?
|
| Blood Group Incompatibility | 3 | 2006 | 23 | 0.230 |
Why?
|
| School Health Services | 1 | 2006 | 19 | 0.230 |
Why?
|
| Apolipoproteins E | 1 | 2006 | 139 | 0.230 |
Why?
|
| Sex Offenses | 1 | 2006 | 26 | 0.230 |
Why?
|
| National Institutes of Health (U.S.) | 3 | 2018 | 140 | 0.230 |
Why?
|
| Models, Theoretical | 3 | 2010 | 508 | 0.230 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2006 | 153 | 0.230 |
Why?
|
| Congenital Abnormalities | 2 | 2003 | 69 | 0.220 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2008 | 324 | 0.220 |
Why?
|
| Organ Preservation | 2 | 2024 | 139 | 0.220 |
Why?
|
| Australia | 2 | 2021 | 125 | 0.220 |
Why?
|
| Papillomavirus Infections | 1 | 2008 | 311 | 0.220 |
Why?
|
| Contraception | 2 | 1996 | 105 | 0.220 |
Why?
|
| Genetics, Behavioral | 1 | 2004 | 22 | 0.220 |
Why?
|
| Algorithms | 3 | 2015 | 2001 | 0.220 |
Why?
|
| Cross-Sectional Studies | 5 | 2025 | 2037 | 0.220 |
Why?
|
| Legal Guardians | 2 | 2006 | 7 | 0.210 |
Why?
|
| Interviews as Topic | 3 | 2026 | 386 | 0.210 |
Why?
|
| Glucose Clamp Technique | 1 | 2004 | 40 | 0.210 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2005 | 98 | 0.210 |
Why?
|
| Parenting | 2 | 2020 | 70 | 0.210 |
Why?
|
| Aged | 11 | 2026 | 21701 | 0.210 |
Why?
|
| Family Health | 2 | 2004 | 156 | 0.200 |
Why?
|
| Parkinson Disease | 1 | 2026 | 186 | 0.200 |
Why?
|
| Privacy | 4 | 2026 | 22 | 0.200 |
Why?
|
| Emotions | 2 | 2019 | 387 | 0.200 |
Why?
|
| Prognosis | 6 | 2018 | 4112 | 0.190 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2026 | 336 | 0.190 |
Why?
|
| Safety | 2 | 2020 | 138 | 0.190 |
Why?
|
| State Government | 2 | 2020 | 26 | 0.190 |
Why?
|
| Civil Rights | 3 | 1997 | 8 | 0.190 |
Why?
|
| Organizational Policy | 2 | 2003 | 56 | 0.180 |
Why?
|
| Perfusion | 1 | 2024 | 271 | 0.180 |
Why?
|
| Obstetrics | 1 | 2004 | 125 | 0.180 |
Why?
|
| Public Housing | 1 | 2002 | 9 | 0.180 |
Why?
|
| Lead Poisoning | 1 | 2002 | 13 | 0.180 |
Why?
|
| Developmental Disabilities | 1 | 2024 | 211 | 0.180 |
Why?
|
| Prevalence | 2 | 2021 | 1384 | 0.180 |
Why?
|
| Religion and Medicine | 2 | 2007 | 130 | 0.170 |
Why?
|
| Canada | 3 | 2009 | 210 | 0.170 |
Why?
|
| Hemoglobinopathies | 2 | 2011 | 9 | 0.170 |
Why?
|
| Cytomegalovirus Infections | 1 | 2022 | 116 | 0.170 |
Why?
|
| Advisory Committees | 2 | 2018 | 95 | 0.170 |
Why?
|
| Chronic Disease | 2 | 2018 | 985 | 0.160 |
Why?
|
| Culture | 3 | 2009 | 57 | 0.160 |
Why?
|
| Neurologists | 1 | 2021 | 10 | 0.160 |
Why?
|
| AIDS Serodiagnosis | 1 | 2001 | 26 | 0.160 |
Why?
|
| Informed Consent By Minors | 1 | 2020 | 2 | 0.160 |
Why?
|
| Patient Self-Determination Act | 1 | 2020 | 4 | 0.160 |
Why?
|
| Principle-Based Ethics | 1 | 2020 | 4 | 0.160 |
Why?
|
| Pancreas Transplantation | 1 | 2021 | 120 | 0.160 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 359 | 0.160 |
Why?
|
| Interinstitutional Relations | 1 | 2000 | 29 | 0.160 |
Why?
|
| Pancreatic Diseases | 1 | 2001 | 61 | 0.160 |
Why?
|
| Thymidine Kinase | 1 | 2020 | 30 | 0.160 |
Why?
|
| Crowdsourcing | 1 | 2020 | 12 | 0.160 |
Why?
|
| Creativity | 1 | 2020 | 5 | 0.160 |
Why?
|
| Genetics, Medical | 4 | 2014 | 51 | 0.160 |
Why?
|
| Morbidity | 1 | 2021 | 162 | 0.160 |
Why?
|
| Patient Care | 3 | 1999 | 99 | 0.160 |
Why?
|
| New York City | 1 | 2020 | 75 | 0.160 |
Why?
|
| Fellowships and Scholarships | 1 | 2022 | 164 | 0.160 |
Why?
|
| Twins, Monozygotic | 1 | 2020 | 58 | 0.160 |
Why?
|
| Intersectoral Collaboration | 1 | 2020 | 11 | 0.160 |
Why?
|
| Prospective Studies | 4 | 2021 | 4798 | 0.160 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2021 | 226 | 0.160 |
Why?
|
| Conflict of Interest | 3 | 2010 | 76 | 0.160 |
Why?
|
| Goals | 3 | 1996 | 69 | 0.160 |
Why?
|
| Medical Futility | 1 | 2020 | 34 | 0.160 |
Why?
|
| Access to Information | 2 | 2015 | 30 | 0.160 |
Why?
|
| Proxy | 1 | 2020 | 27 | 0.150 |
Why?
|
| Rheumatic Fever | 1 | 2019 | 12 | 0.150 |
Why?
|
| Data Interpretation, Statistical | 2 | 2013 | 309 | 0.150 |
Why?
|
| Diabetes Mellitus | 1 | 2007 | 810 | 0.150 |
Why?
|
| Penicillins | 1 | 2019 | 25 | 0.150 |
Why?
|
| Drug Industry | 1 | 2000 | 57 | 0.150 |
Why?
|
| Education, Medical | 1 | 2022 | 229 | 0.150 |
Why?
|
| Men | 2 | 1996 | 10 | 0.150 |
Why?
|
| Democracy | 2 | 1996 | 4 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2024 | 902 | 0.150 |
Why?
|
| Tay-Sachs Disease | 2 | 2011 | 6 | 0.150 |
Why?
|
| Deception | 2 | 1996 | 19 | 0.150 |
Why?
|
| Dialysis | 1 | 2019 | 22 | 0.150 |
Why?
|
| Patient Transfer | 1 | 2020 | 111 | 0.150 |
Why?
|
| Netherlands | 1 | 2019 | 27 | 0.150 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2006 | 849 | 0.150 |
Why?
|
| Global Health | 1 | 2021 | 215 | 0.150 |
Why?
|
| Jews | 2 | 2011 | 42 | 0.150 |
Why?
|
| Genome, Human | 2 | 2015 | 832 | 0.140 |
Why?
|
| Thanatology | 1 | 2018 | 1 | 0.140 |
Why?
|
| DNA, Recombinant | 1 | 2018 | 60 | 0.140 |
Why?
|
| Qualitative Research | 2 | 2026 | 413 | 0.140 |
Why?
|
| Attitude to Death | 1 | 2018 | 31 | 0.140 |
Why?
|
| Information Seeking Behavior | 1 | 2018 | 20 | 0.140 |
Why?
|
| HLA Antigens | 2 | 2010 | 238 | 0.140 |
Why?
|
| Volition | 1 | 2018 | 17 | 0.140 |
Why?
|
| Hymen | 1 | 1998 | 1 | 0.140 |
Why?
|
| Environmental Exposure | 1 | 2002 | 405 | 0.140 |
Why?
|
| Delayed Graft Function | 1 | 2018 | 21 | 0.140 |
Why?
|
| Ectromelia | 1 | 2018 | 4 | 0.140 |
Why?
|
| Ethylene Glycols | 1 | 2018 | 10 | 0.140 |
Why?
|
| Thalidomide | 1 | 2018 | 57 | 0.130 |
Why?
|
| Program Evaluation | 2 | 2009 | 345 | 0.130 |
Why?
|
| Genetic Services | 1 | 1997 | 8 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2000 | 407 | 0.130 |
Why?
|
| Genetic Therapy | 2 | 2018 | 373 | 0.130 |
Why?
|
| Advance Directive Adherence | 1 | 1997 | 7 | 0.130 |
Why?
|
| Transplantation, Homologous | 1 | 2020 | 1026 | 0.130 |
Why?
|
| Christianity | 1 | 1997 | 36 | 0.130 |
Why?
|
| Health Status Disparities | 1 | 2020 | 234 | 0.130 |
Why?
|
| Circumcision, Male | 1 | 1997 | 20 | 0.130 |
Why?
|
| Trust | 2 | 2012 | 106 | 0.130 |
Why?
|
| Psychology, Child | 2 | 2014 | 14 | 0.130 |
Why?
|
| Iatrogenic Disease | 1 | 1997 | 70 | 0.130 |
Why?
|
| Hockey | 1 | 2017 | 9 | 0.130 |
Why?
|
| Patient Preference | 2 | 2016 | 136 | 0.130 |
Why?
|
| Proportional Hazards Models | 2 | 2016 | 920 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
|
| Mutation | 2 | 2023 | 4396 | 0.120 |
Why?
|
| United States Food and Drug Administration | 1 | 2018 | 164 | 0.120 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 125 | 0.120 |
Why?
|
| Apolipoprotein L1 | 1 | 2016 | 8 | 0.120 |
Why?
|
| Predictive Value of Tests | 3 | 2008 | 1778 | 0.120 |
Why?
|
| Social Control, Formal | 1 | 1996 | 10 | 0.120 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1009 | 0.120 |
Why?
|
| Diseases in Twins | 1 | 2016 | 64 | 0.120 |
Why?
|
| Nephrectomy | 2 | 2008 | 290 | 0.120 |
Why?
|
| Fathers | 1 | 1996 | 46 | 0.120 |
Why?
|
| International Cooperation | 1 | 2016 | 132 | 0.120 |
Why?
|
| Sensitivity and Specificity | 2 | 2012 | 1944 | 0.110 |
Why?
|
| Patient Harm | 1 | 2015 | 7 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 4023 | 0.110 |
Why?
|
| Consent Forms | 2 | 2006 | 11 | 0.110 |
Why?
|
| Medicare | 1 | 2019 | 467 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2011 | 1283 | 0.110 |
Why?
|
| Unsafe Sex | 1 | 2015 | 46 | 0.110 |
Why?
|
| Quality of Life | 3 | 2021 | 1891 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 341 | 0.110 |
Why?
|
| Chickenpox | 1 | 1995 | 12 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 337 | 0.110 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2015 | 18 | 0.110 |
Why?
|
| Herpesvirus 3, Human | 1 | 1995 | 24 | 0.110 |
Why?
|
| Peer Review, Research | 2 | 2010 | 41 | 0.110 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 35 | 0.110 |
Why?
|
| Viral Vaccines | 1 | 1995 | 38 | 0.110 |
Why?
|
| Sexual Abstinence | 2 | 2008 | 10 | 0.110 |
Why?
|
| Epidemiologic Factors | 2 | 2005 | 5 | 0.100 |
Why?
|
| Treatment Outcome | 5 | 2024 | 9682 | 0.100 |
Why?
|
| Immunization Schedule | 1 | 2013 | 23 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 194 | 0.100 |
Why?
|
| Quadriplegia | 1 | 1993 | 30 | 0.100 |
Why?
|
| Mental Health | 1 | 2015 | 219 | 0.100 |
Why?
|
| Diet | 1 | 2016 | 468 | 0.100 |
Why?
|
| Religion | 2 | 2008 | 101 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2014 | 166 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2019 | 873 | 0.090 |
Why?
|
| Time Factors | 4 | 2024 | 5555 | 0.090 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2012 | 2 | 0.090 |
Why?
|
| New York | 1 | 2012 | 80 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 2008 | 0.090 |
Why?
|
| Age of Onset | 2 | 2003 | 367 | 0.090 |
Why?
|
| Logistic Models | 1 | 2015 | 1273 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 368 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2018 | 1186 | 0.090 |
Why?
|
| Benchmarking | 1 | 2012 | 86 | 0.090 |
Why?
|
| Genotype | 1 | 2016 | 1888 | 0.090 |
Why?
|
| Brain | 1 | 2022 | 2429 | 0.080 |
Why?
|
| Brazil | 1 | 2011 | 93 | 0.080 |
Why?
|
| Substance-Related Disorders | 1 | 2015 | 470 | 0.080 |
Why?
|
| Carrier State | 1 | 2010 | 40 | 0.080 |
Why?
|
| Health Education | 1 | 2011 | 109 | 0.080 |
Why?
|
| Negotiating | 1 | 2010 | 19 | 0.080 |
Why?
|
| United States Office of Research Integrity | 2 | 2013 | 2 | 0.080 |
Why?
|
| Chimera | 1 | 2010 | 52 | 0.080 |
Why?
|
| Training Support | 1 | 2009 | 23 | 0.080 |
Why?
|
| Gynecology | 1 | 2011 | 135 | 0.080 |
Why?
|
| Mosaicism | 1 | 2010 | 74 | 0.080 |
Why?
|
| Regression Analysis | 1 | 2010 | 577 | 0.070 |
Why?
|
| Hospitals, University | 2 | 2002 | 192 | 0.070 |
Why?
|
| Professional-Patient Relations | 2 | 2002 | 48 | 0.070 |
Why?
|
| Demography | 1 | 2009 | 193 | 0.070 |
Why?
|
| Accreditation | 1 | 2009 | 77 | 0.070 |
Why?
|
| Reimbursement, Incentive | 1 | 2009 | 37 | 0.070 |
Why?
|
| Papanicolaou Test | 1 | 2008 | 39 | 0.070 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 244 | 0.070 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2008 | 6 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 2 | 2002 | 228 | 0.070 |
Why?
|
| ROC Curve | 1 | 2011 | 793 | 0.070 |
Why?
|
| Vaginal Smears | 1 | 2008 | 71 | 0.070 |
Why?
|
| Program Development | 1 | 2009 | 141 | 0.070 |
Why?
|
| Poverty | 1 | 2010 | 214 | 0.070 |
Why?
|
| Terminology as Topic | 1 | 2010 | 225 | 0.070 |
Why?
|
| Family Practice | 1 | 2008 | 74 | 0.070 |
Why?
|
| Retrospective Studies | 1 | 2023 | 10947 | 0.070 |
Why?
|
| Cultural Diversity | 2 | 2021 | 64 | 0.070 |
Why?
|
| Incidence | 1 | 2013 | 1776 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2009 | 218 | 0.070 |
Why?
|
| Telomere | 1 | 2008 | 130 | 0.070 |
Why?
|
| Ethics Committees | 2 | 2008 | 9 | 0.070 |
Why?
|
| Obesity | 2 | 2004 | 1060 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2009 | 257 | 0.060 |
Why?
|
| Growth Hormone | 1 | 2007 | 96 | 0.060 |
Why?
|
| Euthanasia | 1 | 2007 | 17 | 0.060 |
Why?
|
| Hemophilia A | 1 | 2006 | 6 | 0.060 |
Why?
|
| Alleles | 1 | 2010 | 1160 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 2680 | 0.060 |
Why?
|
| Uncertainty | 1 | 2007 | 81 | 0.060 |
Why?
|
| Colorado | 1 | 2006 | 40 | 0.060 |
Why?
|
| Wisconsin | 1 | 2006 | 45 | 0.060 |
Why?
|
| Student Health Services | 1 | 2006 | 1 | 0.060 |
Why?
|
| Florida | 1 | 2006 | 63 | 0.060 |
Why?
|
| Quebec | 1 | 2006 | 13 | 0.060 |
Why?
|
| Group Processes | 2 | 1997 | 30 | 0.060 |
Why?
|
| Adult Children | 1 | 2006 | 13 | 0.060 |
Why?
|
| False Positive Reactions | 1 | 2026 | 215 | 0.060 |
Why?
|
| Medicaid | 1 | 2009 | 276 | 0.060 |
Why?
|
| Fertility | 1 | 2006 | 120 | 0.060 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 548 | 0.060 |
Why?
|
| Medically Uninsured | 1 | 2005 | 72 | 0.060 |
Why?
|
| Reference Standards | 1 | 2005 | 146 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2005 | 155 | 0.060 |
Why?
|
| Delayed Diagnosis | 1 | 2025 | 40 | 0.050 |
Why?
|
| Blood Grouping and Crossmatching | 1 | 2004 | 12 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2005 | 186 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 190 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2013 | 3272 | 0.050 |
Why?
|
| Reproduction | 1 | 2005 | 212 | 0.050 |
Why?
|
| Patient Dropouts | 1 | 2004 | 33 | 0.050 |
Why?
|
| Psychology | 1 | 2003 | 28 | 0.050 |
Why?
|
| Organ Size | 1 | 2024 | 370 | 0.050 |
Why?
|
| Social Environment | 1 | 2004 | 199 | 0.050 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 2003 | 5 | 0.050 |
Why?
|
| Sample Size | 1 | 2003 | 129 | 0.050 |
Why?
|
| Patient Care Team | 1 | 2006 | 318 | 0.050 |
Why?
|
| Voluntary Programs | 1 | 2002 | 1 | 0.050 |
Why?
|
| Child, Hospitalized | 1 | 2003 | 38 | 0.050 |
Why?
|
| Hearing Tests | 1 | 2022 | 12 | 0.050 |
Why?
|
| Contraception Behavior | 1 | 2003 | 32 | 0.050 |
Why?
|
| Reading | 1 | 2022 | 34 | 0.050 |
Why?
|
| Recurrence | 1 | 2006 | 1254 | 0.050 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2003 | 123 | 0.040 |
Why?
|
| Anecdotes as Topic | 1 | 2002 | 6 | 0.040 |
Why?
|
| Operating Rooms | 1 | 2003 | 144 | 0.040 |
Why?
|
| Adoption | 1 | 2001 | 9 | 0.040 |
Why?
|
| Controlled Clinical Trials as Topic | 1 | 2002 | 20 | 0.040 |
Why?
|
| Baltimore | 1 | 2002 | 42 | 0.040 |
Why?
|
| Maryland | 1 | 2002 | 45 | 0.040 |
Why?
|
| Cytomegalovirus | 1 | 2022 | 74 | 0.040 |
Why?
|
| Consciousness | 1 | 2022 | 28 | 0.040 |
Why?
|
| Adolescent Behavior | 1 | 2003 | 118 | 0.040 |
Why?
|
| Social Discrimination | 1 | 2021 | 7 | 0.040 |
Why?
|
| Brain Stem | 1 | 2022 | 167 | 0.040 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2021 | 22 | 0.040 |
Why?
|
| Information Services | 1 | 2001 | 22 | 0.040 |
Why?
|
| Social Class | 1 | 2002 | 156 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2002 | 164 | 0.040 |
Why?
|
| Stereotyping | 1 | 2001 | 21 | 0.040 |
Why?
|
| Alzheimer Disease | 1 | 2006 | 646 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 2783 | 0.040 |
Why?
|
| Probability | 1 | 2001 | 356 | 0.040 |
Why?
|
| Decision Trees | 1 | 2000 | 63 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 7386 | 0.040 |
Why?
|
| Insurance Coverage | 1 | 2002 | 152 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2003 | 340 | 0.040 |
Why?
|
| Patient Acuity | 1 | 2019 | 38 | 0.040 |
Why?
|
| Patients | 1 | 2000 | 104 | 0.040 |
Why?
|
| Advance Care Planning | 1 | 2000 | 45 | 0.040 |
Why?
|
| Animals | 1 | 2019 | 28910 | 0.040 |
Why?
|
| Patient-Centered Care | 1 | 2002 | 233 | 0.040 |
Why?
|
| Genes, BRCA1 | 1 | 2000 | 191 | 0.040 |
Why?
|
| Societies | 1 | 1999 | 15 | 0.040 |
Why?
|
| Containment of Biohazards | 1 | 2018 | 9 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 249 | 0.040 |
Why?
|
| Patient Safety | 1 | 2021 | 234 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2002 | 511 | 0.030 |
Why?
|
| Learning | 1 | 2021 | 310 | 0.030 |
Why?
|
| Academies and Institutes | 2 | 2008 | 35 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2018 | 122 | 0.030 |
Why?
|
| Behavioral Research | 1 | 1997 | 12 | 0.030 |
Why?
|
| Refusal to Participate | 1 | 1997 | 2 | 0.030 |
Why?
|
| Intention | 1 | 1997 | 55 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 299 | 0.030 |
Why?
|
| Rape | 1 | 1996 | 17 | 0.030 |
Why?
|
| Jurisprudence | 1 | 1996 | 23 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2000 | 395 | 0.030 |
Why?
|
| Education | 1 | 1996 | 59 | 0.030 |
Why?
|
| Parental Notification | 1 | 1996 | 7 | 0.030 |
Why?
|
| Social Change | 1 | 1996 | 9 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1527 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 1998 | 799 | 0.030 |
Why?
|
| Italy | 1 | 2015 | 113 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2015 | 93 | 0.030 |
Why?
|
| Sexually Transmitted Diseases | 1 | 1997 | 114 | 0.030 |
Why?
|
| Geography | 1 | 2015 | 249 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 1995 | 139 | 0.030 |
Why?
|
| Politics | 1 | 1994 | 54 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 2040 | 0.020 |
Why?
|
| Patient Rights | 1 | 2013 | 15 | 0.020 |
Why?
|
| Penetrance | 1 | 2013 | 51 | 0.020 |
Why?
|
| Pulmonary Surfactants | 1 | 2013 | 22 | 0.020 |
Why?
|
| Individuality | 1 | 1994 | 120 | 0.020 |
Why?
|
| Human Body | 1 | 1993 | 6 | 0.020 |
Why?
|
| Exome | 1 | 2013 | 145 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1994 | 418 | 0.020 |
Why?
|
| Spinal Cord Injuries | 1 | 1993 | 120 | 0.020 |
Why?
|
| HIV Infections | 1 | 2001 | 1018 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 569 | 0.020 |
Why?
|
| Fees and Charges | 1 | 2009 | 14 | 0.020 |
Why?
|
| Cognition | 1 | 1995 | 669 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2013 | 1145 | 0.020 |
Why?
|
| Oxygen | 1 | 2013 | 772 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 523 | 0.020 |
Why?
|
| Pedigree | 1 | 2004 | 980 | 0.010 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2001 | 36 | 0.010 |
Why?
|
| Hospitals, Pediatric | 1 | 2001 | 128 | 0.010 |
Why?
|